Celltrion | 068270 - Interest Expense On Debt


Celltrion reported KRW19B in Interest Expense on Debt for its fiscal quarter ending in June of 2025.





Interest Expense On Debt Change Date
Akebia Therapeutics 349.66M 12.86M Jun/2026
Alaunos Therapeutics USD 1.07M 215K Jun/2023
Avita Medical AUD 1.25M 100K Jun/2025
Celltrion KRW 19B 1.96B Jun/2025
Dianthus Therapeutics USD 4.44M 263K Sep/2024
Ionis Pharmaceuticals USD 18M 1000K Jun/2026
IQVIA Holdings USD 203M 6M Sep/2026
Moderna USD 10.96B 527M Jun/2026
Organon & Co USD 106M 2M Sep/2026
Revvity USD 22.99M 1.73M Jun/2026
Tectonic Therapeutic USD 237.03M 9.54M Jun/2026
Viatris USD 120.7M 600K Jun/2026
Xeris Pharmaceuticals USD 6.88M 269K Mar/2026